Blood Glucose Meters Market Report 2025

The blood glucose meters market size has grown rapidly in recent years. It will grow from $14.64 billion in 2024 to $16.5 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increasing diabetes prevalence, rise in awareness of diabetes management, growing aging population, home healthcare trends, insurance coverage and reimbursement policies, patient empowerment.

The blood glucose meters market size is expected to see rapid growth in the next few years. It will grow to $25.86 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to continuous glucose monitoring (CGM) integration, smartphone connectivity, artificial intelligence (ai) applications, focus on wearable devices, remote patient monitoring. Major trends in the forecast period include technological advancements in monitoring devices, continuous glucose monitoring (CGM) integration, smartphone connectivity, miniaturization and portability, data analytics and insights, telehealth and remote monitoring.

The rising prevalence of diabetes is significantly driving the growth of the blood glucose meters market. Changing lifestyles, increased alcohol consumption, physical inactivity, and unhealthy eating habits are contributing to a global rise in obesity. This surge in obesity is leading to a higher demand for blood glucose meters. Excess fat tissue releases more fat molecules into the bloodstream, affecting insulin-responsive cells and resulting in reduced insulin sensitivity, which can lead to diabetes. For instance, in December 2022, the National Health Service (NHS), a UK-based public health department, made significant progress in expanding access to advanced blood glucose monitoring technologies. By the end of the year, approximately 200,000 diabetes patients had received continuous glucose monitoring (CGM) devices, marking a notable increase, particularly benefiting type 1 diabetes patients who now have improved tools for effectively managing their condition. Therefore, the increasing prevalence of diabetes is driving the blood glucose meters market.

The increasing demand for wearable devices is expected to drive the growth of the blood glucose meters market in the future. Wearable devices refer to electronic technologies used on the body. Integrating blood glucose monitoring into wearables provides convenience, real-time data, and improved compliance, while also supporting the growth of telehealth and innovation in the market. For instance, in November 2022, the World Health Organization reported that approximately 422 million people worldwide have diabetes. Many patients currently rely on finger-pricking to test their blood glucose levels multiple times a day using glucometers or choose semi-invasive continuous glucose monitors (CGMs). Therefore, the rising demand for wearable devices is significantly contributing to the growth of the blood glucose meters market.

The launch of new products is indeed a key trend gaining traction in the blood glucose meters market. Companies are increasingly focusing on introducing innovative products to enhance their portfolios and solidify their market positions. For example, in January 2022, Roche, a Swiss multinational healthcare company, launched a new point-of-care blood glucose monitor designed specifically for hospital professionals. This monitor features a companion device resembling a touchscreen smartphone that runs its own apps. Additionally, Glytec, a US-based insulin management software company, provided software for the device, including its Glucommander insulin-dosing program, to help streamline the complex task of managing blood sugar levels during a patient’s hospital stay.

Major companies in the blood glucose meters market are developing products such as Eyva to meet the increasing demand for effective monitoring gadgets and gain a competitive edge. Bluesemi launched Eyva in March 2023, a non-invasive blood glucose monitoring gadget providing a home-friendly system, addressing six key human body vitals in just 60 seconds with a touch.

In August 2024, Medical Technology and Devices, an Italy-based leader in consumer health, acquired Ypsomed’s Pen Needles and Blood Glucose Monitoring Systems for an undisclosed amount. This acquisition is expected to enhance Medical Technology and Devices' portfolio in diabetes management, expanding its range of essential medical devices for individuals managing blood glucose levels and insulin delivery. The deal highlights the company's commitment to growth and innovation in consumer healthcare, particularly in addressing chronic conditions like diabetes. Ypsomed, based in Switzerland, specializes in the development and manufacturing of injection and infusion systems for self-medication.

Major companies operating in the blood glucose meters market include Roche Diagnostics, Abbott Laboratories, Medtronic, Bayer Healthcare, LifeScan Inc. (Johnson & Johnson), Ascensia Diabetes Care, ARKRAY Inc., Dexcom Inc., Bionime Corporation, Ypsomed AG, Nova Biomedical, ForaCare Inc., AgaMatrix Inc., Entra Health Systems, i-SENS Inc., Prodigy Diabetes Care, Infopia Co. Ltd., Omron Healthcare Inc., HMD Biomedical Inc., 77 Elektronika Kft, Trividia Health Inc., Nipro Corporation, Beijing Yicheng Bioelectronics Technology Co. Ltd., All Medicus Co. Ltd., Sinocare Inc., Bioland Technology.

North America was the largest region in the global blood glucose meters market in 2024. Western Europe was the second-largest region in the blood glucose meters market. The regions covered in the blood glucose meters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the blood glucose meters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Blood glucose meters are devices designed to measure and display the levels of sugar (glucose) in the blood.

The primary product types within the blood glucose meters market are electrode type blood glucose meters and photoelectric blood glucose meters. Electrode type blood glucose meters consist of electrodes to measure the current generated by an enzymatic reaction involving glucose, an enzyme, and a mediator. These devices find applications in various contexts, including type 1 diabetes, type 2 diabetes, and gestational diabetes. They are utilized by diverse end-users such as hospitals and home care settings.

The blood glucose meters market research report is one of a series of new reports that provides blood glucose meters market statistics, including blood glucose meters industry global market size, regional shares, competitors with a blood glucose meters market share, detailed blood glucose meters market segments, market trends and opportunities, and any further data you may need to thrive in the blood glucose meters industry. This blood glucose meters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood glucose meters consist of sales of electrode-type blood glucose meter and photoelectric blood glucose meter. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.